Bioreactors Market Growth Analysis & Forecast Report | 2021-2027

1
Bioreactors Market Opportunities, Top Key Player
and Forecast To 2027
2
Industry Insights

• The bioreactors market is expected to expand on
  the back of rising requirement for improved
  pharmaceuticals, vaccines, and antibodies
  worldwide. The COVID-19 pandemic has impacted
  millions of lives across the globe. Surge in
  casualties caused by the pandemic has sparked an
  increase in demand for vaccines and other
  biologics to control the spread of the virus.
• To meet the global demand for COVID-19 vaccines,
  biopharmaceutical companies are spearheading
  research and development (RD) activities,
  generating record demand for bioreactors.
  Recently, the Serum Institute of India was said
  to incorporate six 4,000L CSR bioreactors for
  mass producing Novavaxs COVID-19 vaccine
  candidate

3

• Major players operating in the global bioreactors
  industry include Sartorius Stedim Biotech Group,
  Cytiva, Eppendorf, and Merck Group among other
  players. Strategic initiatives like mergers,
  acquisitions, and new product launches, are some
  of the approaches taken by bioreactor
  manufacturers to hold and maintain their position
  in the market.
• Get sample copy of this research report _at_
  https//www.gminsights.com/request-sample/detail/1
  41
• Highlighting an instance, in January 2020,
  Getinge completed the acquisition of Applikon
  Biotechnology B.V., a company involved in
  manufacturing and supply of advanced bioreactors
  for RD in biopharmaceutical companies. The
  strategy was slated to strengthen the firms life
  sciences business with portfolio expansion.

4

Browse complete Table of Contents (ToC) of this
research report _at_ https//www.gminsights.com/toc/
detail/bioreactor-market Chapter 4
Bioreactors Market, By Product Type 4.1 Key
segment trends 4.2 Single-use 4.2.1
Market size, by region, 2016-2027 (USD
Million) 4.3 Reusable 4.3.1 Market size,
by region, 2016-2027 (USD Million)
5
Chapter 5 Bioreactors Market, By Cell 5.1
Key segment trends 5.2 Mammalian cells 5.2.1
Market size, by region, 2016-2027 (USD
Million) 5.3 Bacterial cells 5.3.1 Market
size, by region, 2016-2027 (USD Million) 5.4
Yeast cells 5.4.1 Market size, by region,
2016-2027 (USD Million) 5.5 Others 5.5.1
Market size, by region, 2016-2027 (USD Million)

6
Region

• The Asia Pacific region is expected to witness
  lucrative demand for bioreactors in the estimated
  timeframe. Presence of firms with robust
  manufacturing capacity in the healthcare sector
  and advancements in hi-tech technology may
  support promising developments in the bioreactors
  market.
• As per a report, the Asia Pacific constituted to
  around 20 of the global bioreactors market share
  in 2020. The region offers multiple opportunities
  to national and international pharmaceutical
  companies for collaborations, innovative and
  product development with the government
  initiatives and investments in healthcare and RD
  offering needed support.

7
Key Players

• Merck Group
• Danaher Corporation
• PBS Biotech
• Pierre Guerin Sas (Engie)
• Sartorius Stedim Biotech Group
• Shanghai Bailun Biotechnology Co. Ltd.
• Solaris Biotech Solutions
• Thermo Fisher Scientific

8
Stay In Touch Social Media